Compounded Imiquimod Shows Promise for Ocular Surface Cancers

(MedPage Today) — A compounded form of imiquimod, a topical immune response-modifying therapy approved for basal cell carcinoma and other conditions, showed promise as a treatment for ocular surface malignancies in a small case series.
In five…